Earlier<unk>  trials of<unk><unk>  involved small numbers of patients undergoing a wide range of surgical procedures. In addition, different<unk><unk>  were used without titration to a desired effect (target heart rate). This high degree of heterogeneity resulted in variable opinion regarding the use of<unk><unk>  in the<unk>  phase. Published meta-analyses included these small and relatively heterogeonus trials and resulted in similar variable conclusions. Timing, location, and route of administration also complicate the decision regarding the use of<unk><unk> <unk> ly.
Perioperative β-blockers
Antiplatelet therapy to support PCI
Cardiac risk assessment prior to non-cardiac surgery
Cardiac catheterization pre-procedure evaluation
Emergency bleeding control
Chronic stable angina patient follow-up
Aortic stenosis follow up
Endovascular surgery